Research area
Health & Longevity
Human health, disease, treatment and aging. The largest corpus area supports distinct cancer, neurological and therapeutic navigation.
-
Evidence date ·How immune aging complicates care after a lung transplant
Review or Meta-AnalysisA 2024 review explains infections and blood-cell problems after lung transplant, with mixed outcome findings and proposed, unproven care approaches.
-
Evidence date ·Can experimental scans locate senescent cells in arthritic joints?
Review or Meta-AnalysisAn enzyme-sensitive MRI and PET approach highlights senescence-related signals in cartilage and animal joints, but patient testing remains unresolved.
-
Evidence date ·How a review connects some Chinese medicine interventions to tumor and immune cells
Review or Meta-AnalysisA 2024 review explains two routes from Chinese-medicine interventions to immune change, from tumor tissue to blood, without proving a patient benefit.
-
Evidence date ·How tiny albumin-based carriers are designed around solid tumors
Review or Meta-AnalysisA 2024 review explains how tumor acidity, low oxygen and immune conditions shape albumin-carrier design across cancer treatments and what remains uncertain.
-
Evidence date ·How a DNA-sensing virus helped checkpoint therapy in mouse lung tumors
Peer-Reviewed PaperTracked over timeThree of five mice showed tumor regression with an engineered virus plus PD-L1 blockade. Human safety and tumor selectivity remain unproven.
-
Evidence date ·How a virus used in smallpox vaccines could trigger an immune response beyond a lung tumor
Review or Meta-AnalysisTracked over timeA May 2026 review weighs early clinical findings on vaccinia for lung cancer and the challenges of delivering the virus and sustaining an immune response.
-
Evidence date ·How viruses could link lung cancer cell destruction with an immune response
Review or Meta-AnalysisTracked over timeA 2024 review describes viruses that multiply in cancer cells, break them apart and stimulate immunity; its abstract focuses on rationale, not patient outcomes.
-
Evidence date ·Should researchers remove cells that stop dividing or quiet their signals?
Review or Meta-AnalysisA February 2024 review compares killing senescent cells with suppressing their signals, and explains why tissue markers alone cannot show treatment benefit.
-
Evidence date ·How stressed brain cells and disrupted chemistry connect in Alzheimer’s
Review or Meta-AnalysisA January 2024 review connects oxidative stress and cellular senescence in Alzheimer’s and contrasts antioxidant strategies with mouse senolytic findings.
-
Evidence date ·How production shapes a cancer treatment made from a patient’s cells
Review or Meta-AnalysisA January 2024 review explains where time is spent, how cell growth and gene delivery reshape the product, and why safety remains a separate hurdle.